Diabetes / cancer / metabolic signals

Discovering early biomarkers that connect diabetes and cancer.

KERI is a research project focused on identifying subtle metabolic patterns, integrating clinical and behavioral variables, and testing whether these signals can support earlier risk stratification.

Site structure

Separate pages for a cleaner setup